Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
批准号:
7332209
负责人:
Kerry S Campbell
金额:
$26.28万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-03-01 至 2009-06-30
关键词:
AddressBindingBiochemicalBiologicalBiological ModelsBiological ProcessCD158dCD94 AntigenCell LineCell modelCellsConditionCytolysisCytoplasmic TailDataDeciduaDetectionElementsEpitopesEquilibriumEventEvolutionFamilyFamily memberGoalsHLA G antigenHumanImmunologic SurveillanceIndiumInterferon Type IIInterferonsKIR2DL4 receptorKiller CellsLigandsLinkLymphocyteMHC Class I GenesMalignant NeoplasmsMapsMediatingMessenger RNAMolecularNK Cell ActivationNamesNatural Killer CellsPlayPregnancyPregnant WomenPrimatesProductionProteinsRestRetroviridaeRoleSignal TransductionSignal Transduction PathwaySignaling ProteinSourceStructureTYROBP geneTechniquesTestingTransmembrane DomainTrophoblastic NeoplasmsViralVirusVirus Diseasesbasecytokinecytotoxicityfetalmemberneoplastic cellprogramsreceptorreceptor couplingresponsetrophoblasttumor
中文摘要
描述(由申请人提供):KIR2DL4 (2DL4; CD158d)是人类杀伤细胞igg样受体(KIR)家族成员中结构和功能独特的。研究表明,在分析的所有NK细胞克隆中,2DL4是唯一mRNA表达的KIR,这强烈表明它具有重要的生物学功能。据报道,它也是唯一一种与HLA-G结合的KIR, HLA-G几乎只表达在浸润孕妇母体蜕膜的胎儿来源的滋养细胞上。因此,2DL4已被认为在怀孕期间发挥重要作用,尽管其他功能作用显然是可能的,特别是在癌症和病毒感染中。
英文摘要
DESCRIPTION (provided by applicant): KIR2DL4 (2DL4; CD158d) is structurally and functionally unique among members of the killer cell Ig-like receptor (KIR) family in humans. Studies indicate that 2DL4 is the only KIR for which mRNA is expressed in all NK cell clones analyzed, which strongly indicates that it serves a biologically important function. It is also the only KIR that reportedly binds HLA-G, which is almost exclusively expressed on fetal-derived trophoblasts that infiltrate the maternal decidua in pregnant women. Thus, 2DL4 has been proposed to play an important role during pregnancy, although additional functional roles are clearly possible, particularly in cancer and virus infection.
2DL4 also stands out as the only NK cell activating receptor that reportedly triggers interferon (IFN)gamma production, but not target cell cytotoxicity in resting human NK cells. In contrast, other NK cell activating receptors initiate a functional response program that leads to both IFNgamma production and cytotoxicity. We hypothesize that the distinctive functional attributes of 2DL4 result from physical linkage to a unique transmembrane accessory protein that couples the receptor to signal transduction cascades that differ from those triggered by other activating receptors. Our preliminary data support this hypothesis. We propose to define the molecular basis for the distinctive functional response program activated by 2DL4 and define the elements that differ from those triggered by other NK cell activating receptors that also stimulate cytolytic responses. The results will allow us to define the molecular basis for activating distinct functional response programs in NK cells when they encounter trophoblasts, tumor cells, or virus infected cells. We will pursue the following specific aims to achieve this goal:
1 How do structural elements of KIR2DL4 contribute to its unique functions?
2. What accessory signaling protein is associated with the transmembrane domain of KIR2DL4 to transduce intracellular signals?
3. What are the molecular mechanisms by which KIR2DL4 transduces unique activation signals inhuman NK cells?
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Carbohydrate-mediated modulation of NK cell receptor function: structural and functional influences of heparan sulfate moieties expressed on NK cell surface.
碳水化合物介导的 NK 细胞受体功能调节:NK 细胞表面表达的硫酸乙酰肝素部分的结构和功能影响。
DOI:
10.3389/fonc.2014.00185
发表时间:
2014
期刊:
Frontiers in oncology
影响因子:
4.7
作者:
[Brusilovsky M, Radinsky O, Yossef R, Campbell KS, Porgador A]
通讯作者:
Porgador A
DOI:
10.4049/jimmunol.1000112
发表时间:
2011-03-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Miah SM, Purdy AK, Rodin NB, MacFarlane AW 4th, Oshinsky J, Alvarez-Arias DA, Campbell KS]
通讯作者:
Campbell KS
KIR2DL4 differentially signals downstream functions in human NK cells through distinct structural modules.
KIR2DL4 通过不同的结构模块向人类 NK 细胞中的下游功能发出差异信号。
DOI:
10.4049/jimmunol.180.5.2922
发表时间:
2008
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Miah,SMShahjahan, Hughes,TraceyL, Campbell,KerryS]
通讯作者:
Campbell,KerryS
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells
-
批准号:10319570
-
项目类别:
-
资助金额:$50.65万
-
财政年份:2020
-
负责人:Kerry S Campbell
-
依托单位:
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells
-
批准号:10544158
-
项目类别:
-
资助金额:$50.26万
-
财政年份:2020
-
负责人:Kerry S Campbell
-
依托单位:
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells
-
批准号:10078249
-
项目类别:
-
资助金额:$51.02万
-
财政年份:2020
-
负责人:Kerry S Campbell
-
依托单位:
Understanding Psychosocial and Immunologic Responses in Indolent Lymphoproliferative Disorders
-
批准号:9038558
-
项目类别:
-
资助金额:$66.25万
-
财政年份:2016
-
负责人:Kerry S Campbell
-
依托单位:
Characterization of Type-2 Cytokine-Producing NK Cells
-
批准号:8073248
-
项目类别:
-
资助金额:$1.07万
-
财政年份:2010
-
负责人:Kerry S Campbell
-
依托单位:
Characterization of Type-2 Cytokine-Producing NK Cells
-
批准号:7860305
-
项目类别:
-
资助金额:$27.61万
-
财政年份:2009
-
负责人:Kerry S Campbell
-
依托单位:
Characterization of Type-2 Cytokine-Producing NK Cells
-
批准号:7707072
-
项目类别:
-
资助金额:$21.7万
-
财政年份:2009
-
负责人:Kerry S Campbell
-
依托单位:
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
-
批准号:6860141
-
项目类别:
-
资助金额:$27.78万
-
财政年份:2004
-
负责人:Kerry S Campbell
-
依托单位:
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
-
批准号:7168804
-
项目类别:
-
资助金额:$26.28万
-
财政年份:2004
-
负责人:Kerry S Campbell
-
依托单位:
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
-
批准号:7013613
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2004
-
负责人:Kerry S Campbell
-
依托单位:
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
-
批准号:6724624
-
项目类别:
-
资助金额:$27.88万
-
财政年份:2004
-
负责人:Kerry S Campbell
-
依托单位:
NEGATIVE SIGNALLING BY KILLER CELL INHIBITORY RECEPTORS
-
批准号:6194275
-
项目类别:
-
资助金额:$27.25万
-
财政年份:2000
-
负责人:Kerry S Campbell
-
依托单位:
Molecular Regulation of Inhibitory Killer Cell Ig-like Receptors
-
批准号:8211081
-
项目类别:
-
资助金额:$30.37万
-
财政年份:2000
-
负责人:Kerry S Campbell
-
依托单位:
Molecular Regulation of Inhibitory Killer Cell Ig-like Receptors
-
批准号:7779658
-
项目类别:
-
资助金额:$30.68万
-
财政年份:2000
-
负责人:Kerry S Campbell
-
依托单位:
NEGATIVE SIGNALLING BY KILLER CELL INHIBITORY RECEPTORS
-
批准号:6377620
-
项目类别:
-
资助金额:$27.25万
-
财政年份:2000
-
负责人:Kerry S Campbell
-
依托单位:
NEGATIVE SIGNALLING BY KILLER CELL INHIBITORY RECEPTORS
-
批准号:6514230
-
项目类别:
-
资助金额:$27.25万
-
财政年份:2000
-
负责人:Kerry S Campbell
-
依托单位:
Molecular Regulation of Inhibitory Killer Cell Ig-like Receptors
-
批准号:8606416
-
项目类别:
-
资助金额:$29.52万
-
财政年份:2000
-
负责人:Kerry S Campbell
-
依托单位:
Molecular Regulation of Inhibitory Killer Cell Ig-like Receptors
-
批准号:8433503
-
项目类别:
-
资助金额:$28.61万
-
财政年份:2000
-
负责人:Kerry S Campbell
-
依托单位:
Negative Signalling by Killer Ig-like Receptors
-
批准号:7393731
-
项目类别:
-
资助金额:$28.84万
-
财政年份:2000
-
负责人:Kerry S Campbell
-
依托单位:
Negative Signalling by Killer Ig-like Receptors
-
批准号:7208993
-
项目类别:
-
资助金额:$28.84万
-
财政年份:1999
-
负责人:Kerry S Campbell
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: